Skip to main content
. 2014 May 28;4(5):e004415. doi: 10.1136/bmjopen-2013-004415

Table 1.

Stakeholder characteristics: stakeholders n = 20

Stakeholder Number Comments
Academia (A) 3 Sociologists (2), Pharmacoeconomist (1)
Public service (PS) 5 Politician (1), Medsafe (1), Policy analyst (1), DHB planning (1), Pharmac (1)
Medicine (M) 4 Oncologist (1), General practice (3)
Pharmacist (Ph) 3 DHB (2), Community (1)
Pharmaceutical industry (PI) 2 Manufacturing (1), Representative (1)
Patient Group Representative (PGR) 2 Long-term conditions (2)
Private Health Care Organisation (PHCO) 1 Medical doctor (1)
Additional attributes of stakeholders
▸ 3 Medically qualified doctors ▸ 1 Health professional of Māori ethnicity
▸ 1 Pharmacist ▸ 4 Doctors’ past or current medical group representation
▸ 3 Scientists ▸ 3 GPs’ ethnicities: Māori, Indian and Asian; past or currently practising in areas with high numbers of respective ethnicity, including Pacifica
▸ 1 Medical IT
▸ 1 Therapeutic assessor